Skip to main content
. 2021 Mar 15;31(2):118–128. doi: 10.1089/cap.2020.0100

FIG. 2.

FIG. 2.

Unadjusted mean CGI-S scores (*p < 0.05 was considered statistically significant). Note that in a subset of subjects (n = 12) who participated in a late follow-up visit (29–46 weeks following the final infusion), results continued to improve compared to baseline. The timing of evaluations is as follows: Visit 7 (19 weeks after baseline), Visit 8 (26 weeks after baseline), Visit 9 (29–46 weeks after Visit 8/final infusion and 55–72 weeks after baseline). CGI-S, Clinical Global Impression of Severity.